A Targeted Methylation–Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease

Mahal et al. (Thu,) studied this question.

www.synapsesocial.com/papers/68e5a5e5b6db64358753fdab — DOI: https://doi.org/10.1200/po.24.00269

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort study of 730,000 men in primary care in the UK· 2024 · 46 citations
2. Blood-based tests for multicancer early detection (PATHFINDER): a prospective cohort study· 2023 · 342 citations
3. The enigma of race and prostate cancer· 2023 · 3 citations
4. Comparing Survival of a Sample to That of a Standard Population· 2003 · 158 citations
5. Overdiagnosis and Overtreatment of Prostate Cancer· 2014 · 952 citations